AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36105647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bud planting method with potato buds of 7 cm length (T3)
Number of subjects: 4
Study 36105647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bud planting method with terminal buds (T4)
Number of subjects: 4
Study 36105647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bud planting method with different lengths (3 cm, 5 cm, 7 cm)
Number of subjects: 4
Study 36105647 — intervention group
Group type: COMPARATOR
Intervention: Natural control (CK) treatment
Number of subjects: 4
Study 33926922 — intervention group
Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 31
Study 33926922 — intervention group
Group type: COMPARATOR
Intervention: Sham transplantation
Number of subjects: 31
Study 35363600 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0
Study 35363600 — intervention group
Group type: COMPARATOR
Intervention: Baseline FVC bronchodilator responsiveness
Number of subjects: 0
Study 35363600 — intervention group
Group type: COMPARATOR
Intervention: Early lung function reduction
Number of subjects: 0
Study 35363600 — intervention group
Group type: COMPARATOR
Intervention: Interactions between lung function reduction and treatment assignment
Number of subjects: 0
Study 35363600 — intervention group
Group type: COMPARATOR
Intervention: Baseline bronchodilator responsiveness measures
Number of subjects: 0
Study 33529588 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% topical ocular reproxalap
Number of subjects: 300
Study 33529588 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 300
Study 33382780 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Hexbio®) containing Lactobacillus sp and Bifidobacterium sp at 30 X 10^9 CFU with fructo-oligosaccharide
Number of subjects: 48
Study 33382780 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic (Hexbio®)
Number of subjects: 48
Study 33382780 — intervention group
Group type: COMPARATOR
Intervention: Placebo (fermented milk)
Number of subjects: 48
Study 35400075 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min aerobic exercise
Number of subjects: 74
Study 35400075 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-min sitting naps
Number of subjects: 74
Study 35400075 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 74
Study 33904659 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning exercise (7:00)
Number of subjects: 11
Study 33904659 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon exercise (16:00)
Number of subjects: 11
Study 33904659 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 11
Study 32326902 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse mentor supported facilities
Number of subjects: 5240
Study 32326902 — intervention group
Group type: COMPARATOR
Intervention: Other facilities or home deliveries
Number of subjects: 5240
Study 35882461 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support package consisting of evidence-based strategies (remind clinicians; facilitation; conduct educational meetings; develop a formal implementation blueprint; purposely re-examine the implementation; conduct ongoing training)
Number of subjects: 0
Study 35882461 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation support package
Number of subjects: 0
Study 32333057 — intervention group
Group type: EXPERIMENTAL
Intervention: Attune TKA
Number of subjects: 200
Study 32333057 — intervention group
Group type: COMPARATOR
Intervention: PFC Sigma
Number of subjects: 200
Study 36288835 — intervention group
Group type: EXPERIMENTAL
Intervention: Selinexor, cyclophosphamide and prednisolone (SCP)
Number of subjects: 0
Study 36288835 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide and prednisolone (CP)
Number of subjects: 0
Study 34784373 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS (15 Hz)
Number of subjects: 62
Study 34784373 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 62
Study 34788741 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - walking/jogging at RPE 11-17 for 25 minutes
Number of subjects: 15
Study 34788741 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE) - walking at RPE 11-13 for 30 minutes
Number of subjects: 15
Study 33179456 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 1848
Study 33179456 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 1848
Study 36184209 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein dairy drink
Number of subjects: 25
Study 36184209 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-enriched berry purées
Number of subjects: 25
Study 36184209 — intervention group
Group type: COMPARATOR
Intervention: Protein-free reference
Number of subjects: 25
Study 36184209 — intervention group
Group type: COMPARATOR
Intervention: Low-berry reference
Number of subjects: 25
Study 32895334 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-Assisted Sigmoidoscopy (WAS)
Number of subjects: 1123
Study 32895334 — intervention group
Group type: COMPARATOR
Intervention: CO2 technique
Number of subjects: 1123
Study 32408117 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron supplementation (100 mg/day)
Number of subjects: 60
Study 32408117 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron supplementation
Number of subjects: 60
Study 32408117 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 33737036 — intervention group
Group type: EXPERIMENTAL
Intervention: iStent inject®
Number of subjects: 505
Study 33737036 — intervention group
Group type: COMPARATOR
Intervention: surgery alone
Number of subjects: 505
Study 32649638 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 241
Study 34047206 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived importance of physical activity (PA) before/after school
Number of subjects: 1015
Study 32876858 — intervention group
Group type: EXPERIMENTAL
Intervention: Qingfei Yihuo Capsules (QYCs)
Number of subjects: 60
Study 32876858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 35230212 — intervention group
Group type: EXPERIMENTAL
Intervention: BetterBack model of care (MoC)
Number of subjects: 500
Study 35230212 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 500
Study 33563546 — intervention group
Group type: EXPERIMENTAL
Intervention: Axial slicing
Number of subjects: 128
Study 33563546 — intervention group
Group type: COMPARATOR
Intervention: Bivalving
Number of subjects: 128
Study 32162502 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Strength Training (CST)
Number of subjects: 20
Study 32162502 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study 36451559 — intervention group
Group type: EXPERIMENTAL
Intervention: Licorice gargle juice for 1 and 2 days
Number of subjects: 54
Study 36451559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 33100187 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 62
Study 33100187 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 62
Study 32790451 — intervention group
Group type: EXPERIMENTAL
Intervention: MEMS (Mobile Enhancement of Motivation in Schizophrenia)
Number of subjects: 56
Study 32790451 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 56
Study 35972345 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRAS model (developed using variables: ascites discomfort score, plasma sodium levels, and a composite of ascites accumulation and diuretic treatment)
Number of subjects: 1162
Study 35972345 — intervention group
Group type: EXPERIMENTAL
Intervention: CIRAS model
Number of subjects: 1162
Study 34845062 — intervention group
Group type: COMPARATOR
Intervention: Weight Loss (WL)
Number of subjects: 172
Study 34845062 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic Excursion Minimization (GEM)
Number of subjects: 172
Study 34845062 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM
Number of subjects: 172
Study 35643868 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosutinib 400 mg once daily
Number of subjects: 536
Study 35643868 — intervention group
Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 536
Study 34544463 — intervention group
Group type: EXPERIMENTAL
Intervention: Solnatide (AP301), administered twice daily for 7 days
Number of subjects: 0
Study 34544463 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered twice daily for 7 days
Number of subjects: 0
Study 32998815 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunosuppression
Number of subjects: 0
Study 32998815 — intervention group
Group type: COMPARATOR
Intervention: Intensive supportive care
Number of subjects: 0
Study 35189571 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue isometric pressure exercises using the Iowa Oral Performance Instrument with an increasing scheme of 5% load weekly and traditional tongue therapy for 8 weeks
Number of subjects: 60
Study 35189571 — intervention group
Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 60
Study 32789772 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular CAT sub-registry
Number of subjects: 1128
Study 32789772 — intervention group
Group type: EXPERIMENTAL
Intervention: Special CAT sub-registry
Number of subjects: 1128
Study 32677390 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 101
Study 32677390 — intervention group
Group type: COMPARATOR
Intervention: Simple ESTD (Control)
Number of subjects: 101
Study 34255938 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose/Metformin Fixed-Dose Combination (50 mg/500 mg)
Number of subjects: 0
Study 34255938 — intervention group
Group type: COMPARATOR
Intervention: Loose combination of individual components (Acarbose and Metformin)
Number of subjects: 0
Study 32516507 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDesign Logic rotary files
Number of subjects: 88
Study 32516507 — intervention group
Group type: COMPARATOR
Intervention: K-file hand files
Number of subjects: 88
Study 33036918 — intervention group
Group type: EXPERIMENTAL
Intervention: Counting and goal setting intervention (n = 85)
Number of subjects: 165
Study 33036918 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 80)
Number of subjects: 165
Study 33036918 — intervention group
Group type: COMPARATOR
Intervention: Intervention group vs Control group
Number of subjects: 165
Study 34644419 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 10% spray (50 mg)
Number of subjects: 539
Study 34644419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539
Study 34229292 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anaesthesia (Group OF) with dexmedetomidine, esketamine and sevoflurane
Number of subjects: 152
Study 34229292 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based anaesthesia (Group C) with sufentanil and sevoflurane
Number of subjects: 152
Study 34229292 — intervention group
Group type: COMPARATOR
Intervention: Opioid-based anaesthesia (Group C)
Number of subjects: 152
Study 34229292 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free anaesthesia (Group OF)
Number of subjects: 152
Study 35946449 — intervention group
Group type: EXPERIMENTAL
Intervention: KliniTrayTM (radiopaque tissue transfer and X-ray system)
Number of subjects: 117
Study 35946449 — intervention group
Group type: COMPARATOR
Intervention: ISO (institutional standard procedure)
Number of subjects: 117
Study 35946449 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate re-excision due to positive SR
Number of subjects: 117
Study 33947618 — intervention group
Group type: EXPERIMENTAL
Intervention: dp‐ucMGP (dephosphorylated, undercarboxylated matrix Gla protein) levels in AAA cases
Number of subjects: 676
Study 33947618 — intervention group
Group type: COMPARATOR
Intervention: dp‐ucMGP (dephosphorylated, undercarboxylated matrix Gla protein) levels in controls
Number of subjects: 676
Study 32544700 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 50 mg/day
Number of subjects: 1262
Study 32544700 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 100 mg/day
Number of subjects: 1262
Study 32544700 — intervention group
Group type: EXPERIMENTAL
Intervention: BRV 200 mg/day
Number of subjects: 1262
Study 32544700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1262
Study 36329920 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth
Number of subjects: 221
Study 36329920 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth with interactivity
Number of subjects: 221
Study 36329920 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 221
Study 32994487 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain fermented milk product (1 bottle/day)
Number of subjects: 96
Study 32994487 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain fermented milk product (3 bottles/day)
Number of subjects: 96
Study 32994487 — intervention group
Group type: COMPARATOR
Intervention: Control product
Number of subjects: 96
Study 33091142 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-coated PEEK cages (group A)
Number of subjects: 60
Study 33091142 — intervention group
Group type: COMPARATOR
Intervention: Uncoated PEEK cages (group B)
Number of subjects: 60
Study 33091142 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 32480401 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple Heron's formula
Number of subjects: 60
Study 33836807 — intervention group
Group type: EXPERIMENTAL
Intervention: Yijinjing exercise intervention combined with routine rehabilitation therapy (40 min/session, 3 sessions/week for 12 weeks)
Number of subjects: 72
Study 33836807 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation therapies (occupational therapy, physical therapy, acupuncture therapy, health education) 5 times a week for 3 months
Number of subjects: 72
Study 32331366 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Children, Healthy Families, Healthy Communities Program (multi-level strategies for obesity prevention)
Number of subjects: 104
Study 32331366 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 32331366 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Children, Healthy Families, Healthy Communities Program
Number of subjects: 104
Study 35552197 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic treatment (2x10^9 cfu/day for 30 days)
Number of subjects: 300
Study 35552197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 33057696 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (machine learning mortality predictions with behavioral nudges)
Number of subjects: 14607
Study 33057696 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 14607
Study 34825728 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 54
Study 34825728 — intervention group
Group type: COMPARATOR
Intervention: Moderate Intensity Continuous Training (MICT)
Number of subjects: 54
Study 32027620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus NK cells
Number of subjects: 109
Study 32027620 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab alone
Number of subjects: 109
Study 32027620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus NK cells (TPS 50% or higher)
Number of subjects: 109
Study 32027620 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple courses of NK cell infusion
Number of subjects: 109
Study 32027620 — intervention group
Group type: EXPERIMENTAL
Intervention: Single course of NK cell infusion
Number of subjects: 109
Study 35794080 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation of afatinib dimaleate (40 mg)
Number of subjects: 60
Study 35794080 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation of afatinib dimaleate (40 mg)
Number of subjects: 60
Study 35794080 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 60
Study 32638995 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive self-care health management program
Number of subjects: 540
Study 32638995 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 540
Study 34789636 — intervention group
Group type: EXPERIMENTAL
Intervention: Night denture (ND) placement
Number of subjects: 0
Study 34789636 — intervention group
Group type: COMPARATOR
Intervention: Control group (without ND placement)
Number of subjects: 0
Study 33515500 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance intravenous gemcitabine (1250 mg/m2 on days 1 and 8, in cycles of 21 days) plus supportive care
Number of subjects: 130
Study 33515500 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care alone
Number of subjects: 130
Study 33475580 — intervention group
Group type: COMPARATOR
Intervention: Closed reduction and immobilisation (Group-A)
Number of subjects: 70
Study 33475580 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction with internal fixation (Group-B)
Number of subjects: 70
Study 37002475 — intervention group
Group type: EXPERIMENTAL
Intervention: YOGA-DP (Yoga Programme for T2DM Prevention)
Number of subjects: 65
Study 37002475 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard care
Number of subjects: 65
Study 33420185 — intervention group
Group type: EXPERIMENTAL
Intervention: HYAJOINT Plus (3 ml, 20 mg/ml) followed by PRP (3 ml)
Number of subjects: 85
Study 33420185 — intervention group
Group type: COMPARATOR
Intervention: PRP (3 ml)
Number of subjects: 85
Study 32563284 — intervention group
Group type: EXPERIMENTAL
Intervention: Innovative study designs and new methodological approaches to statistical analyses
Number of subjects: 0
Study 32563284 — intervention group
Group type: EXPERIMENTAL
Intervention: Current study designs
Number of subjects: 0
Study 32563284 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical analysis methods
Number of subjects: 0
Study 33538094 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 210
Study 33538094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 32553394 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing unilateral ECT with antidepressants
Number of subjects: 18
Study 32553394 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to bilateral ECT
Number of subjects: 18
Study 32553394 — intervention group
Group type: COMPARATOR
Intervention: No intervention reported
Number of subjects: 18
Study 32553394 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 18
Study 36041934 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal fixation (PerFix)
Number of subjects: 245
Study 36041934 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fixation)
Number of subjects: 245
Study 32845090 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents (EES)
Number of subjects: 426
Study 32968171 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS (100‐500 Hz) over bilateral PPC for 15 minutes at 1.5 mA
Number of subjects: 40
Study 32968171 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40
Study 35719197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabbage leaf application for 1-hour duration once a day (n = 20)
Number of subjects: 40
Study 35719197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling gel pad application for 20 minutes duration once a day (n = 20)
Number of subjects: 40
Study 35719197 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac gel application 4 times a day (n = 20)
Number of subjects: 40
Study 34524048 — intervention group
Group type: EXPERIMENTAL
Intervention: Interventions to prevent mother to child transmission of HIV
Number of subjects: 0
Study 34524048 — intervention group
Group type: COMPARATOR
Intervention: Standard of care interventions
Number of subjects: 0
Study 34741815 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment intervention (tailored geriatric assessment summary and management recommendations)
Number of subjects: 718
Study 34741815 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric assessment intervention
Number of subjects: 718
Study 34741815 — intervention group
Group type: COMPARATOR
Intervention: Usual care (no geriatric assessment summary or management recommendations)
Number of subjects: 718
Study 34741815 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 718
Study 35667492 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 0
Study 35667492 — intervention group
Group type: COMPARATOR
Intervention: Individual and Group Supportive Therapy (IGST)
Number of subjects: 0
Study 616116188 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based DSME plus homecare
Number of subjects: 180
Study 616116188 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based DSME
Number of subjects: 180
Study 616116188 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (usual care)
Number of subjects: 180
Study 616116188 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital-based DSME and Hospital-based DSME plus homecare
Number of subjects: 180
Study 35081576 — intervention group
Group type: EXPERIMENTAL
Intervention: Integra (ADM + STSG)
Number of subjects: 0
Study 35081576 — intervention group
Group type: EXPERIMENTAL
Intervention: Matriderm (ADM + STSG)
Number of subjects: 0
Study 35081576 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelnac (ADM + STSG)
Number of subjects: 0
Study 35081576 — intervention group
Group type: COMPARATOR
Intervention: Control (STSG without ADM)
Number of subjects: 0
Study 34146476 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic microscopy-detected infections
Number of subjects: 531
Study 34146476 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic submicroscopic infections
Number of subjects: 531
Study 34146476 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptomatic infections
Number of subjects: 531